---
schema_version: "secwatch.filing_event.v1"
accession: "0001393905-24-000114"
form_type: "8-K"
ticker: "STME"
cik: "0001493712"
company_name: "Stimcell Energetics Inc."
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:17:09.097537+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cell MedX elects four directors and increases authorized shares to 7.5B

## Summary
- Elected directors: David Jeffs, George Adams, Joao (John) Da Costa, Amir Vahabzadeh effective April 1, 2024.
- Authorized common stock increased from 300M to 7.5B shares ($0.001 par value).
- Increase approved by written consent of stockholders holding 66% of outstanding shares.
- No other material corporate changes were disclosed in the filing.

## SEC filing metadata
- accession: 0001393905-24-000114
- form_type: 8-K
- ticker: STME
- cik: 0001493712
- company_name: Stimcell Energetics Inc.
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/0001393905-24-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/cmxc-20240401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001393905-24-000114
- JSON: https://secwatch.observer/filing/0001393905-24-000114.json
- Plain text: https://secwatch.observer/filing/0001393905-24-000114.txt

## Key facts
- Governance Changes
  Stimcell Energetics Inc.: Increase in authorized capital from 300,000,000 to 7,500,000,000 shares of common stock (effective 2024-04-01).
  - Change: charter amendment
  - Effective: 2024-04-01
  source text: On April 1, 2024, Cell MedX Corp. (the “Company”), amended its articles of incorporation to increase the authorized capital of the Company from 300,000,000 shares of common stock, par value $0.001 (the “Common Stock”) to 7,500,000,000 shares of Common Stock (the “Increase in Authorized Capital”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/0001393905-24-000114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.